Efficacy, Safety, and Tolerability of Perhexiline in Subjects With Hypertrophic Cardiomyopathy and Heart Failure
Condition(s):Hypertrophic CardiomyopathyLast Updated:July 14, 2017Withdrawn
Hide Studies Not Open or Pending
Condition(s):Hypertrophic CardiomyopathyLast Updated:July 14, 2017Withdrawn
Condition(s):Williams Beuren Syndrome; Autism Spectrum DisorderLast Updated:September 27, 2019Completed
Condition(s):Hypertrophic CardiomyopathyLast Updated:September 14, 2016Completed
Condition(s):Hypertrophic CardiomyopathyLast Updated:September 24, 2018Terminated
Condition(s):Hypertrophic CardiomyopathyLast Updated:February 5, 2019Completed
Condition(s):Hypertrophic Obstructive CardiomyopathyLast Updated:July 2, 2015Completed
Condition(s):Fragile X Syndrome; Angelman Syndrome; Prader-Willi Syndrome; Dup15Q Syndrome; Duchenne Muscular Dystrophy; Phelan-McDermid Syndrome; Rett Syndrome; Smith Magenis Syndrome; Williams Syndrome; Turner Syndrome; Klinefelter Syndrome; Chromosome 22q11.2 Deletion Syndrome; Tuberous Sclerosis; Down SyndromeLast Updated:April 28, 2023Enrolling by invitation
Condition(s):Williams Syndrome; AnxietyLast Updated:October 18, 2019Unknown status
Condition(s):Hypertrophic Cardiomyopathy; Depression; Anxiety; PsychotherapyLast Updated:October 15, 2018Unknown status
Condition(s):Williams Syndrome; LipedemaLast Updated:October 19, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.